Researchers have investigated the relationship between PRMT5 and Wnt/β-catenin signalling as well as AKT/GSK3β proliferative signalling in three different types of NHL cell lines, clinical samples, and mouse primary lymphoma cells. The gene discussed is PRMT5; the disease is lymphoma.